Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Sale |
2025-02-05 4:02 pm |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
22,183 | $3.283 | $72,827 | 159,724 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 7:54 pm |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
9,593 | $2.3125 | $22,184 | 631,907 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-11 4:05 pm |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
27,500 | $2.2 | $60,500 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Option Award |
2025-02-19 6:25 pm |
N/A 2035-02-14 |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
455,900 | $0 | 615,624 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 4:10 pm |
N/A 2034-06-19 |
SCYNEXIS INC | SCYX | HASTINGS DAVID C Director |
23,000 | $0 | 69,183 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:54 pm |
N/A 2034-02-01 |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
562,500 | $0 | 631,907 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-23 4:08 pm |
N/A N/A |
SCYNEXIS INC | SCYX | HASTINGS DAVID C Director |
10,000 | $0 | 23,183 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 8:06 pm |
N/A 2033-06-14 |
SCYNEXIS INC | SCYX | HASTINGS DAVID C Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:11 pm |
N/A 2033-02-01 |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
395,000 | $0 | 395,000 (Direct) |
View |
Ownership |
2023-01-03 9:04 pm |
N/A 2038-01-02 |
Vascular Biogenics Ltd. | VBLT | HASTINGS DAVID C Director |
0 | $0 | 224,113 (Direct) |
View |
| 2022-07-07 Equity Swap |
2022-07-11 4:05 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
22,000 | $2.2 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:05 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
37,583 | $0 | 0 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:06 pm |
N/A 2032-06-16 |
SCYNEXIS INC | SCYX | HASTINGS DAVID C Director |
10,000 | $0 | 23,183 (Direct) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:01 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
26,583 | $0 | 26,583 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-20 5:55 pm |
N/A 2032-01-20 |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
285,000 | $2.81 | 285,000 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:01 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
27,500 | $0 | 49,500 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 08:31 am |
N/A 2031-06-15 |
SCYNEXIS INC | SCYX | HASTINGS DAVID C Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 10:33 am |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2020-07-06 Option Award(A) |
2021-03-31 4:04 pm |
N/A 2030-07-05 |
SCYNEXIS INC | SCYX | HASTINGS DAVID C Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-02-13 Option Award |
2021-02-17 5:06 pm |
N/A 2031-02-13 |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2020-06-10 Option Award |
2020-10-06 4:32 pm |
N/A 2030-06-09 |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
11,000 | $0 | 11,000 (Direct) |
View |
| 2020-07-06 Option Award |
2020-07-08 4:11 pm |
N/A 2030-07-05 |
SCYNEXIS INC | SCYX | HASTINGS DAVID C Director |
45,000 | $0 | 45,000 (Direct) |
View |